Satellite Banner
Technology Networks Header
Sunday, December 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Activ8rlives to Develop its First Medical Smartwatch
Friday, December 19, 2014
BuddyWOTCH for continuous monitoring of oxygenation for UK’s Chronic Obstructive Pulmonary Disease patients.

Ebola Antigens and Antibodies for ELISA
Friday, December 19, 2014
AMSBIO products for the development of an ELISA detection assay for the Ebola virus.

Revolutionize Routine Medical Testing with Latest ‘Super-Control’ from Randox
Wednesday, December 17, 2014
'Super Control' will revolutionize quality control in laboratories.

QIAGEN to Distribute altona Diagnostic’s RealStar® Ebolavirus RT-PCR Kit 1.0
Tuesday, December 09, 2014
New molecular diagnostic test detects but does not differentiate all existing strains of Ebola virus.

IDT and Ubiquitome Partner to Develop Mobile Ebola Test
Wednesday, December 03, 2014
Handheld, battery-powered Freedom4 enables rapid field deployment of gold standard molecular test.

Sophisticated HIV Diagnostics Adapted for Remote Areas
Tuesday, December 02, 2014
New tool is low-cost, with no electricity needed - NIH study.

PGDx Launches CancerSelect™ Targeted Gene Panel for Patients and Physicians
Friday, November 14, 2014
Company is first to offer highly informative panel that targets the most actionable cancer genes and compares tumor and normal DNA.

Randox Launches Data Management ‘Advisor’ To Optimise Lab Quality Control
Friday, November 14, 2014
Global clinical diagnostics firm Randox Laboratories has launched a new ‘Advisor’ application to complement its interlaboratory data management software Acusera 24•7 Live Online.

IDT Launches GMP MGB Eclipse® Probes for In Vitro Diagnostic Use
Tuesday, November 11, 2014
High quality, excellent service, and product transparency for human qPCR diagnostic applications.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 489
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn